The Role of Medicinal Chemistry in Drug Discovery
The 2018 Mattson Symposium will be held on the Pullman campus of Washington State University on September 22nd 2018. This all-day event is presented in partnership with AbbVie (a biopharmaceutical company) and will focus on drug discovery. Following the presentations, a social hour and dinner will be hosted at the Elson S. Floyd Cultural Center.
Modern Drug Discovery, i.e., the path from the initial disease target idea and therapeutic rationale to a new marketed drug is a formidably complex and resource-intensive undertaking. Medicinal chemists play a critical role in many of the key stages of drug discovery and development. This year’s Matteson Symposium focuses on the role of medicinal chemistry and related technologies in discovering new chemical entities designed to address many debilitating diseases, with the aim of significantly benefiting the lives of many patients around the world. Presentations from seasoned drug hunters from AbbVie and other companies will cover many topics including the discovery of drugs already on the market.
Schedule of Events Saturday, September 22, 2018
- 8:30 Breakfast – Spark Reception Area
All talks are in Spark G 45
- 9:10 Dr. Stevan Djuric, Vice President and Distinguished Research Fellow, Discovery Chemistry and Technology, AbbVie
- 10:00 Dr. Michael Michaelides, Senior Research Fellow and Head of Oncology Chemistry, AbbVie
- 10:50 Coffee Break
- 11:10 Dr. Russ Thomas, Director of Strategic Alliances, Axxam SpA, Milan, Italy
- 12:00 Lunch – Spark Reception Area
- 1:00 Dr. David DeGoey, Research Fellow, Discovery Chemistry and Technology, AbbVie
- 1:50 Coffee Break
- 2:10 Dr. Adrian Hobson, Research Fellow, Global Biologics, AbbVie
- 3:00 Dr. Paul Leeson, Director, Leeson Consulting and former Head of Medicinal Chemistry at Astra Zeneca, Charnwood, UK.
- 3:50 Dr. Donald Matteson, Emeritus Professor, Washington State University
- 4:35 Social – Elson S. Floyd Cultural Center
- 6:00 Dinner Begins – Elson S. Floyd Cultural Center